Cardica designs and manufactures proprietary stapling devices for surgical procedures. Cardica’s stapling technology is designed to minimize operating time and to enable minimally-invasive and robot-assisted surgeries. The company manufactures its automated anastomosis systems, the C-Port^® Distal Anastomosis Systems and PAS-Port^® Proximal Anastomosis System, for coronary artery bypass graft (CABG) surgery and has shipped over 25,000 units throughout the world. In addition, Cardica is developing the Cardica Microcutter, a true multi-fire endoscopic stapling device designed to be used in a variety of procedures, including bariatric, thoracic and general surgery.

MICROCUTTER NEWS

This summer, Cardica continues to make great strides in bringing its MicroCutter product line to the marketplace. The first commercial device in this product line, the Microcutter XPRESS™ 30, passed internal design validation allowing Cardica to apply the CE Mark to this device. Less than one month later, the XPRESS 30 was used in humans for the first time by Dr. Andreas Kuthe in several laparoscopic surgeries. Cardica remains committed to working with a selected European centers to incorporate feedback into successive iterations of this product and future products within the Microcutter product line. The Cardica Microcutter product line requires a 510(k) review and is not yet commercially available in the U.S.  To read more, please see the press releases listed below.

Cardica Applies CE Mark to Microcutter XPRESS(TM) 30 Surgical Cutting and Stapling Device

Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESS(TM) 30 Surgical Cutting and Stapling Device